One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy

This study investigated one-year outcomes of treatment with one session of intravitreal recombinant tissue plasminogen activator, ranibizumab, and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy (PCV). An extended study of a previous prospective trial of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitagawa, Yorihisa, Shimada, Hiroyuki, Mori, Ryusaburo, Tanaka, Koji, Wakatsuki, Yu, Onoe, Hajime, Kaneko, Hiroyuki, Machida, Yumiko, Nakashizuka, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032067/
https://www.ncbi.nlm.nih.gov/pubmed/35456268
http://dx.doi.org/10.3390/jcm11082175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032067/
https://www.ncbi.nlm.nih.gov/pubmed/35456268
http://dx.doi.org/10.3390/jcm11082175

Ejemplares similares